CHL Chlamydia Rapid Test Device/Strip

Chlamydia is a common bacterial infection caused by Chlamydia trachomatis. It is usually transmitted through sexual contact and may affect the cervix, urethra, rectum, throat, or reproductive tract. Many people may not show symptoms, which makes testing important after possible exposure or when recommended by a healthcare professional.

• The CHL Chlamydia Rapid Test Device/Strip is designed for fast, simple, and professional screening.
• Rapid chlamydia testing is useful in settings where early screening, quick workflow, and easy visual interpretation are important.
• Chlamydia infection may be asymptomatic, so testing can help support clinical evaluation and timely medical guidance.
• Rapid antigen tests like the CHL Chlamydia Rapid Test Device/Strip can support screening workflows, but final diagnosis should be interpreted with symptoms, medical history, and confirmatory testing when required.

The CHL Chlamydia Rapid Test Device/Strip by LARKSOIS Pharma may be used in professional diagnostic and healthcare environments.

Applications

• Chlamydia infection screening
• Hospitals and clinical laboratories
• Diagnostic centers and clinics
• Sexual health screening programs
• Infectious disease testing workflows
• Professional in-vitro diagnostic use
• International diagnostic distribution
• Healthcare procurement and supply channels

• The CHL Chlamydia Rapid Test Device/Strip works through lateral flow chromatographic immunoassay technology.
• The prepared urine or swab specimen is added to the test device according to the product insert.
• If Chlamydia trachomatis antigen is present at or above the cut-off level, a visible test line appears.
• A control line confirms correct sample migration and valid test performance. The result should always be read according to the official LARKSOIS Pharma product insert.

The CHL Chlamydia Rapid Test Device/Strip uses rapid chromatographic immunoassay technology for qualitative detection of Chlamydia trachomatis antigen.

Benefits

• Rapid qualitative detection
• Suitable for urine and swab specimens
• Simple procedure
• Easy visual interpretation
• No advanced instrument required
• Supports infectious disease screening
• Suitable for hospitals, clinics, laboratories, and distributors
• Developed for professional international diagnostic supply

The CHL Chlamydia Rapid Test Device/Strip may be used with urine, male urethral swab, or female cervical swab specimens. Correct specimen collection and handling are important for reliable screening performance.

Guidance

• Use approved specimen types only
• Use clean, properly collected specimens
• Avoid contaminated samples
• Follow the kit insert exactly
• Test specimens as soon as possible
• Use correct extraction buffer and timing
• Read results only within the recommended time window

Note

Specimen collection, extraction, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The CHL Chlamydia Rapid Test Device/Strip by LARKSOIS Pharma has a stated cut-off of 1e5 org/test. This means the test is designed to detect Chlamydia trachomatis antigen at or above the validated detection level. LARKSOIS Pharma should publish exact performance details according to the final product insert, technical file, and regulatory documentation.

• Chlamydia testing is important because many infected people may not show symptoms.
• Untreated chlamydia may lead to complications, so timely screening and medical follow-up are important.
• A rapid screening result should be interpreted with clinical findings, patient history, exposure risk, and additional laboratory testing where required.
• Healthcare professionals should decide final diagnosis and treatment based on complete clinical evaluation.

The CHL Chlamydia Rapid Test Device/Strip is intended as a qualitative screening aid and should not be used as the only basis for diagnosis or treatment decisions.

Instructions

• A positive result suggests Chlamydia trachomatis antigen detection but does not confirm disease severity
• A negative result does not always rule out chlamydia infection
• Testing too early after exposure may affect detection
• Incorrect specimen collection may affect results
• Diluted urine or contaminated samples may affect accuracy
• Expired or poorly stored test kits may affect performance
• Confirmatory testing may be required depending on clinical condition and local guidelines

Instructions

• Rapid qualitative detection
• Suitable for urine and swab specimens
• Simple procedure
• Easy visual interpretation
• No advanced instrument required
• Supports infectious disease screening
• Suitable for hospitals, clinics, laboratories, and distributors
• Developed for professional international diagnostic supply

Note

The CHL Chlamydia Rapid Test Device/Strip by LARKSOIS Pharma is developed for professional users who need fast and practical infectious disease screening support.

Steps

• Bring the test device, specimen, and extraction materials to the recommended testing condition if required
• Open the sealed pouch only when ready to test
• Collect urine, male urethral swab, or female cervical swab according to the product insert
• Prepare the specimen using the correct extraction buffer and timing
• Apply the prepared specimen to the test device as instructed
• Wait for the test reaction to complete within the stated time
• Read the result within the approved interpretation window
• Dispose of used materials according to laboratory safety rules

Note

The exact procedure must follow the official LARKSOIS Pharma product insert supplied with the CHL Chlamydia Rapid Test Device/Strip.

Positive

A positive result usually shows both the control line and test line. This suggests that Chlamydia trachomatis antigen may be present in the specimen. The result should be interpreted with symptoms, exposure history, and other laboratory findings.

Negative

A negative result usually shows the control line only. This suggests that Chlamydia trachomatis antigen was not detected or was below the test detection level at the time of testing. A negative result does not always rule out infection.

Invalid

If the control line does not appear, the result is invalid. The test should be repeated with a new device and properly collected specimen according to the product insert.

Instructions

• Store the test device according to the product label instructions
• Keep the test sealed until use
• Protect from moisture
• Avoid direct sunlight and extreme temperatures
• Do not use expired, damaged, or opened test devices
• Bring samples and kit components to room temperature before testing if recommended
• Use only within the stated expiry period

Instructions

• For professional in-vitro diagnostic use only
• Do not reuse the test device or strip
• Use only approved specimen types
• Follow correct collection and extraction steps
• Read results within the recommended time window
• Negative results do not fully rule out infection
• Positive results should be reviewed with clinical findings
• Confirmatory testing may be required

LARKSOIS Pharma provides international-quality diagnostic and pharmaceutical products for healthcare markets worldwide. The CHL Chlamydia Rapid Test Device/Strip is designed for professional infectious disease testing, reliable screening support, and global diagnostic distribution.

Advantages

• International diagnostic product focus
• Reliable rapid testing solutions
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product format
• Supports infectious disease screening workflows
• Practical urine and swab specimen testing format
• Quality-focused standards under LARKSOIS Pharma